Abstract
Intrapartum chemoprophylaxis is currently the most effective preventive strategy against the neonatal early-onset group B streptococcal infection. The principal controversies on strategies for intrapartum antibiotic administration, possible adverse effects, management of newborn and possible future preventive strategies reported in the literature are considered.
| Original language | English |
|---|---|
| Pages (from-to) | 38-42 |
| Number of pages | 5 |
| Journal | Journal of Maternal-Fetal and Neonatal Medicine |
| Volume | 22 |
| Issue number | SUPPL. 3 |
| DOIs | |
| Publication status | Published - 2009 |
Fingerprint
Keywords
- Early onset neonatal sepsis
- Group B streptococcus
- Intrapartum antibiotic
- Neonatal infection
- Streptococcal prevention
- Vaccine
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Obstetrics and Gynaecology
Cite this
Prevention of early onset group B streptococcal disease : Controversial issues. / Tzialla, Chryssoula; Borghesi, Alessandro; Garofoli, Francesca; Bollani, Lina; Longo, Stefania; Stronati, Mauro.
In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 22, No. SUPPL. 3, 2009, p. 38-42.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Prevention of early onset group B streptococcal disease
T2 - Controversial issues
AU - Tzialla, Chryssoula
AU - Borghesi, Alessandro
AU - Garofoli, Francesca
AU - Bollani, Lina
AU - Longo, Stefania
AU - Stronati, Mauro
PY - 2009
Y1 - 2009
N2 - Intrapartum chemoprophylaxis is currently the most effective preventive strategy against the neonatal early-onset group B streptococcal infection. The principal controversies on strategies for intrapartum antibiotic administration, possible adverse effects, management of newborn and possible future preventive strategies reported in the literature are considered.
AB - Intrapartum chemoprophylaxis is currently the most effective preventive strategy against the neonatal early-onset group B streptococcal infection. The principal controversies on strategies for intrapartum antibiotic administration, possible adverse effects, management of newborn and possible future preventive strategies reported in the literature are considered.
KW - Early onset neonatal sepsis
KW - Group B streptococcus
KW - Intrapartum antibiotic
KW - Neonatal infection
KW - Streptococcal prevention
KW - Vaccine
UR - http://www.scopus.com/inward/record.url?scp=70449382754&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449382754&partnerID=8YFLogxK
U2 - 10.1080/14767050903211521
DO - 10.1080/14767050903211521
M3 - Article
C2 - 19718586
AN - SCOPUS:70449382754
VL - 22
SP - 38
EP - 42
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
SN - 1476-7058
IS - SUPPL. 3
ER -